Pfizer to manufacture remdesivir for Gilead

By The Science Advisory Board staff writers

August 7, 2020 -- Pfizer has inked a multiyear agreement with Gilead Sciences to manufacture and supply Gilead's investigational antiviral drug remdesivir, joining other external manufacturing organizations in supporting efforts to scale up supply for the treatment of COVID-19.

Under the agreement, Pfizer will provide contract manufacturing services at its McPherson, KS, facility to manufacture and supply remdesivir for Gilead. This is part of the company's commitment to working with other pharmaceutical companies to address the COVID-19 crisis.


Copyright © 2020 scienceboard.net
 


MemberID or email address:

Password:
Forgot your password?